Cargando…

Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis

BACKGROUND: Uncertainty regarding clopidogrel effectiveness attenuation because of a drug-drug interaction with proton pump inhibitors (PPI) has led to conflicting guidelines on concomitant therapy. In particular, the effect of this interaction in patients who undergo a percutaneous coronary interve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Serbin, Michael A., Guzauskas, Gregory F., Veenstra, David L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2016
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141192/ https://www.ncbi.nlm.nih.gov/pubmed/27459657 http://dx.doi.org/10.18553/jmcp.2016.22.8.939

Ejemplares similares

Prescription behavior for gastroprotective drugs in new users as a result of communications regarding clopidogrel – proton pump inhibitor interaction
por: Kruik‐Kollöffel, Willemien J., et al.
Publicado: (2016)

The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?
por: Sharma, Rakesh K, et al.
Publicado: (2010)

The potential interaction between clopidogrel and proton pump inhibitors: a systematic review
por: Lima, Joao Paulo de Aquino, et al.
Publicado: (2010)

Impact of proton pump inhibitors on efficacy of clopidogrel: Review of evidence
por: Mistry, Suresh D., et al.
Publicado: (2011)

Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases
por: Gurbel, Paul A, et al.
Publicado: (2010)

Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs
por: Douglas, Ian J, et al.
Publicado: (2012)

Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update
por: Wedemeyer, Ralph-Steven, et al.
Publicado: (2014)

Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?
por: Kenngott, S, et al.
Publicado: (2010)

Impact of Proton Pump Inhibitor Therapy on the Efficacy of Clopidogrel in the CAPRIE and CREDO Trials
por: Dunn, Steven P., et al.
Publicado: (2013)

Treatment Outcomes of Clopidogrel in Patients With ACS and Diabetes Undergoing PCI-Analysis of Beijing Municipal Medical Insurance Database
por: Wang, Weihao, et al.
Publicado: (2021)

Interaction of proton pump inhibitors with cytochromes P450: consequences for drug interactions.
por: Meyer, U. A.
Publicado: (1996)

Proton pump inhibitors and colorectal cancer: A systematic review
por: Patel, Agastya, et al.
Publicado: (2021)

Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction
por: Lee, Yong Kang, et al.
Publicado: (2023)

Drug–drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure
por: Raoul, J.L., et al.
Publicado: (2023)

Investigation of the interaction between proton pump inhibitors and clopidogrel using VerifyNow P2Y12 assay
por: Lin, Sheng-Feng, et al.
Publicado: (2020)

Risk of bias in non-randomized observational studies assessing the relationship between proton-pump inhibitors and adverse kidney outcomes: a systematic review
por: Rajan, Pradeep, et al.
Publicado: (2022)

Changes in Practice Patterns of Clopidogrel in Combination with Proton Pump Inhibitors after an FDA Safety Communication
por: Guérin, Annie, et al.
Publicado: (2016)

The effect of ticagrelor on coronary microvascular function after PCI in patients with ACS compared to clopidogrel: A systematic review and meta-analysis
por: Qiu, Xiaohan, et al.
Publicado: (2023)

Pancytopenia Due to Possible Drug–Drug Interactions Between Low-Dose Methotrexate and Proton Pump Inhibitors
por: Tao, Dan, et al.
Publicado: (2022)

Use of Clopidogrel and Proton Pump Inhibitors Alone or in Combinations in Persons with Diabetes in Denmark; Potential for CYP2C19 Genotype-Guided Drug Therapy
por: Westergaard, Niels, et al.
Publicado: (2021)

Intermittent concurrent use of clopidogrel and proton pump inhibitors did not increase risk of adverse clinical outcomes in Chinese patients with coronary artery disease
por: He, Wanbing, et al.
Publicado: (2021)

The Use of Proton Pump Inhibitors and COVID-19: A Systematic Review and Meta-Analysis
por: Fatima, Kaneez, et al.
Publicado: (2022)

Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention
por: Kwan, Joanne, et al.
Publicado: (2011)

Outcome of stroke patients on clopidogrel plus proton-pump inhibitors: a single-center cohort study
por: Alghamdi, Rahaf A., et al.
Publicado: (2019)

Proton Pump Inhibitor and Clopidogrel Use After Percutaneous Coronary Intervention and Risk of Major Cardiovascular Events
por: Maret-Ouda, John, et al.
Publicado: (2021)

Risk factors for adverse drug reactions associated with clopidogrel therapy
por: Mugosa, Snezana, et al.
Publicado: (2022)

Drug-Coated Balloon Treatment for ACS Induced by Myocardial Bridging: An Intravascular Ultrasound-Guided PCI
por: Shen, Linghong, et al.
Publicado: (2020)

Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view
por: Abrignani, Maurizio Giuseppe, et al.
Publicado: (2023)

Proton Pump Inhibitors and the Risk of Adverse Cardiac Events
por: Juurlink, David N., et al.
Publicado: (2013)

Adverse Effects of Proton Pump Inhibitors—Evidence and Plausibility
por: Fossmark, Reidar, et al.
Publicado: (2019)

Adverse Effects Associated with Proton Pump Inhibitor Use
por: Yibirin, Marcel, et al.
Publicado: (2021)

Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding
por: Wang, Qing, et al.
Publicado: (2014)

Impact of concomitant use of proton pump inhibitors and clopidogrel or ticagrelor on clinical outcomes in patients with acute coronary syndrome
por: Yan, Yan, et al.
Publicado: (2016)

Influence of individual proton pump inhibitors on clinical outcomes in patients receiving clopidogrel following percutaneous coronary intervention
por: Lee, Dongyoung, et al.
Publicado: (2021)

Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis
por: Ma, Yun-Jie, et al.
Publicado: (2019)

Paradoxical relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis
por: Zippi, Maddalena, et al.
Publicado: (2021)

Effects of Clopidogrel and Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus after Drug-Eluting Stent Implantation: A Nationwide Cohort Study
por: Hsieh, Chi-Feng, et al.
Publicado: (2015)

The Association between Baseline Proton Pump Inhibitors, Immune Checkpoint Inhibitors, and Chemotherapy: A Systematic Review with Network Meta-Analysis
por: Chang, Yu, et al.
Publicado: (2022)

The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-Analysis
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal
por: Poly, Tahmina Nasrin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_smidf1fm67e9159uubnkusfcba